Highly prevalent TERT promoter mutations in aggressive thyroid cancers

Mutations 1 295 228 C>T and 1 295 250 C>T (termed C228T and C250T respectively), corresponding to −124 C>T and −146 C>T from the translation start site in the promoter of the telomerase reverse transcriptase ( TERT ) gene, have recently been reported in human cancers, but not in thyroid cancers yet.... View More